Director at DUKE Robotics (DUKR) awarded options for 4,000 shares at $7.88

Rhea-AI Filing Summary

DUKE Robotics Corp. director Antebi Eran received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share. The option was fully unheld before this award, so his post-transaction derivative holdings in this grant are 4,000 options. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. This is a compensation-related award, not an open-market trade.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Antebi Eran

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock	4,000	$0.00	--

Holdings After Transaction: Option to Purchase Common Stock — 4,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Antebi Eran

(Last) (First) (Middle)

C/O DUKE ROBOTICS CORP.

10 HARIMON STREET

(Street)

MEVO CARMEL SCIENCE & IND PARK L3 2069203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DUKE Robotics Corp. [ DUKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$7.88	03/10/2026		A		4,000(1)		(1)	03/10/2032	Common Stock	4,000	$0	4,000	D

Explanation of Responses:

1. The option vests in three equal annual installments beginning on March 10, 2027.

	/s/ Eran Antebi	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DUKE Robotics (DUKR) report for Antebi Eran?

DUKE Robotics reported that director Antebi Eran received an option grant for 4,000 shares of common stock. This is a compensation-related award, not an open-market stock purchase or sale, and represents his entire position in this specific option grant after the transaction.

What is the exercise price of Antebi Eran’s new DUKE Robotics (DUKR) stock options?

The new stock options granted to Antebi Eran have an exercise price of $7.88 per share. This is the price at which he can buy DUKE Robotics common stock if he chooses to exercise the options in the future, once they are vested and before expiration.

How many DUKE Robotics (DUKR) options does Antebi Eran hold after this Form 4 filing?

After the transaction, Antebi Eran holds 4,000 options to purchase DUKE Robotics common stock from this grant. The filing shows zero options from this grant before the award, so the entire 4,000-option position results from this single compensation-related acquisition.

When do Antebi Eran’s DUKE Robotics (DUKR) stock options vest?

The stock options granted to Antebi Eran vest in three equal annual installments beginning on March 10, 2027. This means one-third of the 4,000 options vest each year over three years, assuming he continues to meet the vesting conditions specified for the award.

When do Antebi Eran’s DUKE Robotics (DUKR) options expire?

The option grant to Antebi Eran expires on March 10, 2032. He can only exercise the options between the time each portion vests, starting March 10, 2027, and the final expiration date, subject to any additional terms in the underlying option agreement.

Was Antebi Eran’s DUKE Robotics (DUKR) transaction a stock purchase or sale?

The transaction was neither a stock purchase nor sale in the open market. It was an option grant classified as a “Grant, award, or other acquisition,” giving him rights to buy 4,000 DUKE Robotics shares at $7.88 per share in the future, subject to vesting and expiration.